(Q36883798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

New perspectives and strategy research biomarkers for hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Patrick Pham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Maâmar Reffas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Mohamed Takka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Antoinette Lemoine

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Brigitte Debuire

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

1 reference

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

Clinical Chemistry and Laboratory Medicine

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1169-1179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Modeling the hepatitis C virus epidemic in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Hepatocellular carcinoma in cirrhotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Alphafetoprotein: an obituary

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

AFP-L3: a new generation of tumor marker for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Early detection and curative treatment of early-stage hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Structures of disease-specific serum alpha-fetoprotein isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Liver pathology in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Alcohol and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Genetic aspects of hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Microsatellite instability and p53 mutations in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Microsatellite instability associated with hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Microsatellite instability and loss of heterozygosity at DNA mismatch repair gene loci occurs during hepatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Review of genetic and epigenetic alterations in hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Expression profiling and identification of novel genes in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Distinctive gene expression profiles associated with Hepatitis B virus x protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Proteomics for hepatocellular carcinoma marker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Epidemiology of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.262

21 January 2018

Identifiers

DOI

10.1515/CCLM.2007.262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17635075%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference